AFP Clinical Answers

Augmentation Therapy, Menstrual Bleeding, VTE, Pancreatic Cancer, Acute Kidney Injury

 

Am Fam Physician. 2020 Nov 15;102(9):587.

What is the evidence for augmentation therapy in patients with treatment-resistant depression?

There is weak research to guide treatment decisions for patients who have not responded to two adequate courses of antidepressant treatment. One randomized controlled trial of cognitive behavior therapy showed benefit over placebo. Aripiprazole (Abilify) had a small effect, but no other antipsychotic or lithium provided benefit over placebo.

https://www.aafp.org/afp/2019/0915/p376.html

Are hormonal contraceptives effective in decreasing heavy menstrual bleeding?

Combined oral contraceptives decrease the number of women reporting heavy menstrual bleeding over six months more than placebo, with a number needed to treat (NNT) of 2.7. The levonorgestrel-releasing intrauterine system (Mirena) is more effective, with an NNT of 3 to decrease heavy menstrual bleeding compared with combined oral contraceptives.

https://www.aafp.org/afp/2019/1201/p677.html

What testing should be used to diagnose venous thromboembolism (VTE)?

The American Society of Hematology recommends determining pretest probability using the Wells, Geneva, or Constans score to select testing to diagnose or rule out VTE. A d-dimer test alone can be used to rule out VTE for patients with a low or intermediate pretest probability of pulmonary embolism, low pretest probability of lower extremity deep venous thrombosis (DVT), or low pretest probability of upper extremity DVT. In patients with a low or intermediate pretest probability of pulmonary embolism but a positive d-dimer result, a ventilation-perfusion scan is recommended over computed tomography pulmonary angiography (CTPA), but CTPA is recommended for patients with a high pretest probability. Ultrasonography is recommended as the initial test for patients with a high pretest probability of lower extremity or upper extremity DVT with confirmatory testing if negative.

https://www.aafp.org/afp/2019/1201/p716.html

Which patients should be screened for pancreatic cancer?

 

 

Copyright © 2020 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP


Editor's Collections


More in Pubmed

MOST RECENT ISSUE


Jan 15, 2021

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article